BECN1 and colorectal cancer: We found that by promoting HMGB1 cytosolic translocation and inhibition of Beclin-1-PI3K-III core complex formation through the MEK/ERK1/2 pathway, naphplatin modulates CTSL and autophagy-lysosome function and enhances its sensitivity towards colorectal cancer (Fig. 5a).